Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Evanthia T Roussos

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
Cancer Immunology Research|May 11, 2022
Revival and Recharacterization of a Preclinical Model of Hormone-Dependent Breast Cancer to Study ImmunotherapyEvanthia T Roussos Torres
Expert Review of Anticancer Therapy|January 13, 2021
Adopting an alternative structure for clinical trials in immunotherapyEvanthia T Roussos Torres, Alan L Epstein
Breast Cancer Research and Treatment|October 30, 2021
Emerging combination immunotherapy strategies for breast cancer: dual immune checkpoint modulation, antibody-drug conjugates and bispecific antibodiesEvanthia T Roussos Torres, Leisha A Emens
Nature Reviews. Cancer|July 23, 2011
Chemotaxis in cancerEvanthia T Roussos, John S Condeelis, Antonia Patsialou
Biochimica Et Biophysica Acta|February 17, 2006
Genetic analysis of the diabetes-prone C57BLKS/J mouse strain reveals genetic contribution from multiple strainsHui Z Mao, Evanthia T Roussos, Miklós Péterfy
Frontiers in Molecular Biosciences|June 18, 2021
Lymph Node Immune Profiles as Predictive Biomarkers for Immune Checkpoint Inhibitor ResponseEmily F Goode, Evanthia T Roussos Torres, Sheeba Irshad
Cancer Immunology Research|February 27, 2023
Myeloid-Derived Suppressor-Cell Dynamics Control Outcomes in the Metastatic NicheJesse Kreger, Evanthia T Roussos Torres, Adam L MacLean
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|April 22, 2020
Best Foot Forward: Neoadjuvant Systemic Therapy as Standard of Care in Triple-Negative and HER2-Positive Breast CancerPriyanka Sharma, Roisin M Connolly, Evanthia T Roussos Torres, et al.
NPJ Systems Biology and Applications|April 10, 2025
Modeling the dynamics of EMT reveals genes associated with pan-cancer intermediate states and plasticityMeiLu McDermott, Riddhee Mehta, Evanthia T Roussos Torres, et al.
Bioinformatics (Oxford, England)|February 2, 2026
Inference of marker genes of subtle cell state changes via iLR: iterative logistic regressionYingtong Liu, Aaron G Baugh, Evanthia T Roussos Torres, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Cancer Immunology Research|May 11, 2022
Revival and Recharacterization of a Preclinical Model of Hormone-Dependent Breast Cancer to Study ImmunotherapyEvanthia T Roussos Torres
Expert Review of Anticancer Therapy|January 13, 2021
Adopting an alternative structure for clinical trials in immunotherapyEvanthia T Roussos Torres, Alan L Epstein
Breast Cancer Research and Treatment|October 30, 2021
Emerging combination immunotherapy strategies for breast cancer: dual immune checkpoint modulation, antibody-drug conjugates and bispecific antibodiesEvanthia T Roussos Torres, Leisha A Emens
Nature Reviews. Cancer|July 23, 2011
Chemotaxis in cancerEvanthia T Roussos, John S Condeelis, Antonia Patsialou
Biochimica Et Biophysica Acta|February 17, 2006
Genetic analysis of the diabetes-prone C57BLKS/J mouse strain reveals genetic contribution from multiple strainsHui Z Mao, Evanthia T Roussos, Miklós Péterfy
Frontiers in Molecular Biosciences|June 18, 2021
Lymph Node Immune Profiles as Predictive Biomarkers for Immune Checkpoint Inhibitor ResponseEmily F Goode, Evanthia T Roussos Torres, Sheeba Irshad
Cancer Immunology Research|February 27, 2023
Myeloid-Derived Suppressor-Cell Dynamics Control Outcomes in the Metastatic NicheJesse Kreger, Evanthia T Roussos Torres, Adam L MacLean
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|April 22, 2020
Best Foot Forward: Neoadjuvant Systemic Therapy as Standard of Care in Triple-Negative and HER2-Positive Breast CancerPriyanka Sharma, Roisin M Connolly, Evanthia T Roussos Torres, et al.
NPJ Systems Biology and Applications|April 10, 2025
Modeling the dynamics of EMT reveals genes associated with pan-cancer intermediate states and plasticityMeiLu McDermott, Riddhee Mehta, Evanthia T Roussos Torres, et al.
Bioinformatics (Oxford, England)|February 2, 2026
Inference of marker genes of subtle cell state changes via iLR: iterative logistic regressionYingtong Liu, Aaron G Baugh, Evanthia T Roussos Torres, et al.
Pageof 6